Articles

Journey Medical Corporation and Dr. Reddy’s Laboratories Ltd. have joined forces for the development and commercialization of DFD-19 as a treatment for rosacea.

Journey Medical, Dr. Reddy’s to Commercialize and Develop DFD-29 for Rosacea  

Lisette Hilton is president of Words Come Alive, based in Boca Raton, Florida.

Dermoscopy cannot diagnose D folliculorum proliferation but can reveal specific findings in patients with papulopustular rosacea. 

Dermoscopy Falls Short in Diagnosing Demodex

Emmy Graber, MD, presented the updates in acne and rosacea treatments at the SCALE Acne and Rosacea update on June 9, 2021. 

What’s New in Acne and Rosacea for 2021?

Nonprescription moisturizers and cleansers can play an integral role in delivering positive treatment outcomes for patients with rosacea. 

OTC Skin Care Products Enhance Rosacea Therapy

Recent therapeutic advances in topical and systemic therapy offer new options for cases that have not responded to established treatment approaches.

Off-label Sarecycline Combats Papulopustular Rosacea

John Jesitus is a medical writer based in Westminster, CO.

In treatments addressing muscular contraction, botulinum toxin inhibits nerves that innervate blood vessels from releasing acetylcholine, which triggers vasodilation. Its  
impact on the innate immune system suggests that botulinum toxin may also help reduce recalcitrant rosacea-related papules and pustules. 
 

Neuromodulators Combat Key Rosacea Challenges

New treatments continue to expand therapy options, but a cure remains elusive.

2021 Rosacea Report

Findings from a recent study indirectly support therapeutic approaches aimed at restoring the dermal matrix.

Collagen Degeneration Linked to Rosacea

This formulation could be first FDA-approved single-agent E-BPO prescription drug to treat rosacea. 

New E-BPO Improves Rosacea 

Recent research shows prolonged face-mask usage leads to negative quality-of-life impact and worsening of disease for rosacea. 